| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | UT2BA2O3KN |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108283 |
| FDA SRS | UT2BA2O3KN |
CONTENTS
| Status: | Phase 2 |
| Entry Type: | Antibody |
| UNII: | UT2BA2O3KN |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108283 |
| FDA SRS | UT2BA2O3KN |